MyoPax

MYOPOWERS MEDICAL TECHNOLOGIES SA

This company develops implantable artificial muscle technology to restore muscle function for patients suffering from conditions such as stress urinary incontinence.

Juvena Therapeutics

This biotechnology company develops protein-based regenerative medicines for patients with chronic muscle and metabolic diseases.

IMEL Biotherapeutics

This company develops mitochondrial replacement cell therapies for patients with genetic mitochondrial disorders and age-related diseases.

Cellergy Therapeutics

This biotechnology company develops purified mitochondrial transplantation therapies to treat patients with neurodegenerative diseases, muscle degeneration and age-related conditions.

Myosin Therapeutics

This biopharmaceutical company develops small molecule therapies targeting molecular nanomotors to treat aggressive cancers and neurological disorders for patients with unmet medical needs.

ARTHEx Biotech

This clinical-stage biotechnology company develops RNA-based treatments for patients with rare neuromuscular genetic diseases, including myotonic dystrophy type 1.

Capricor

This biotechnology company develops cell and exosome-based therapies to treat Duchenne muscular dystrophy and other serious diseases for patients.

Soufflé Therapeutics

This biotechnology company develops cell-specific oligonucleotide therapies for patients with muscular dystrophy, heart failure, and metabolic disorders.